Drug General Information (ID: DDIBKZSQ0P)
  Drug Name Tramadol Drug Info Lumefantrine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Analgesics Antimalarial Agents
  Structure

 Mechanism of Tramadol-Lumefantrine Interaction (Severity Level: Major)
     Increased risk of prolong QT interval Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Tramadol Lumefantrine
      Mechanism Prolong QT interval Prolong QT interval
      Key Mechanism Factor 1
Factor Name QT interval
Factor Description Long QT syndrome is a heart signaling disorder that can cause a fast, chaotic heartbeat (arrhythmia). Many people may not exhibit symptoms, and usually the condition is detected during routine medical tests. In others, the most common symptoms include: sudden fainting, palpitations, dizziness, seizures, sudden death.
      Mechanism Description
  • Increased risk of prolong QT interval by the combination of Tramadol and Lumefantrine 

Recommended Action
      Management Coadministration of artemether-lumefantrine with tramadol should generally be avoided. If concomitant use is required, careful consideration of the effects on tramadol and M1 is recommended. Patients should be monitored for opioid withdrawal, seizures, and serotonin syndrome, and care should be exercised in patients suspected to be at an increased risk of torsade de pointes. If artemether-lumefantrine is discontinued, consider reducing the tramadol dose (taking into account the elimination half-life of lumefantrine [3 to 6 days]) until stable drug effects are achieved and monitor for respiratory depression and sedation. Patients should be advised to seek prompt medical attention if they experience symptoms that could indicate the occurrence of torsade de pointes such as dizziness, lightheadedness, fainting, palpitation, irregular heart rhythm, shortness of breath, or syncope.

References
1 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
2 Product Information. Coartem (artemether-lumefantrine). Novartis Pharmaceuticals, East Hanover, NJ.
3 Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.